Brief Description
Narra Biosciences develops anti-cancer therapeutics based on anti-cancer properties of the soybean protein Lunasin (from the Tagalog word "lunas" for cure. The technology can be used to identify potential drug targets and diagnostic biomarkers, and also as a research tool for understanding epigenetic control of gene expression during cancer development. The company was founded by UC Berkeley Nutritional Science and Toxicology Professor Ben de Lumen based on research discoveries in his lab.
Timeline
- 2015. Company founded
Inventors
Benito de Lumen, Alfredo Galvez